Results 121 to 130 of about 2,316 (158)
Surface-Modified Nanozymes for Enhanced and Selective Catalysis. [PDF]
Chen X, Willner I.
europepmc +1 more source
Nucleic Acid-Modified Nanoparticles for Cancer Therapeutic Applications. [PDF]
Qin Y, Chen X, Willner I.
europepmc +1 more source
A "metabolic dual-clamp" strategy for glucose metabolism blockade and cascade-amplified tumor immunotherapy. [PDF]
Chang P +12 more
europepmc +1 more source
Framework Nucleic Acids as a Nanocontainer for Delivering Heterogeneous Molecular Drugs. [PDF]
Yang M +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Therapeutic applications of AS1411 aptamer, an update review
International Journal of Biological Macromolecules, 2020Nucleolin or C23, is one of the most abundant non-ribosomal phosphoproteins of nucleolus. However, in several cancers, nucleolin is highly expressed both intracellularly and on the cell surface. So, it is considered as a potential target for the diagnosis and cancer therapy.
Rezvan Yazdian–Robati +2 more
exaly +3 more sources
The effect of AS1411 aptamer on anti-tumor effects of dendrimers containing SN38
Journal of Drug Delivery Science and Technology, 2022Seyedeh Alia Moosavian +1 more
exaly +2 more sources
Corneal neovascularization is inhibited with nucleolin-binding aptamer, AS1411
Experimental Eye Research, 2020Corneal neovascularization (CNV) is a common sight-threatening pathology that can be induced by a variety of inflammatory and angiogenic stimuli. Current CNV treatments include anti-inflammatory drugs and antibody-based inhibitors of vascular endothelial growth factor (VEGF).
Oscar, Vivanco-Rojas +8 more
openaire +2 more sources
Aptamer AS1411 utilized for super-resolution imaging of nucleolin
Talanta, 2020Nucleolin (NCL) is a multifunctional protein that mainly localizes in the nucleolus and also distributes in the nucleoplasm, cytoplasm and cell membrane. Most studies focus on its biofunctions in cell activities and diseases, however, its detailed distribution and organization pattern in situ remains obscure.
Yingying, Jing +5 more
openaire +2 more sources
Aptamer imaging with Cu-64 labeled AS1411: Preliminary assessment in lung cancer
Nuclear Medicine and Biology, 2014AS1411 is a 26-base guanine-rich oligonucleotide aptamer shown binding to surface nucleolin, a protein over-expressed in multiple cancer cells, thus AS1411 labeled with a PET isotope can be explored as a potential diagnostic imaging agent. Our objective was to perform preliminary biological characterization of (64)Cu-labeled AS1411 in vitro and in vivo.
Junling Li, Tariq Malik, John O Trent
exaly +3 more sources

